Literature DB >> 20403968

Airway mast cells in a rhesus model of childhood allergic airways disease.

Laura S Van Winkle1, Gregory L Baker, Jackie K W Chan, Edward S Schelegle, Charles G Plopper.   

Abstract

Asthma is a leading cause of morbidity in children. Risk factors include chronic exposure to allergens and air pollution. While chronically activated mast cells contribute to the pathophysiology of asthma in part through their proteases such as chymase and tryptase, previous studies of airway mast cell abundance and distribution in asthmatics have been inconsistent. To determine whether repeated episodic exposures to environmental pollutants during postnatal lung development alter airway mast cell abundance and distribution, we exposed infant rhesus monkeys to a known human allergen, house dust mite antigen (HDMA), and/or a known environmental pollutant, ozone (O(3)), and quantitatively compared the abundance of tryptase- or chymase-positive mast cells in three airway levels. Mast cells are resident in multiple compartments of the airway wall in infant rhesus monkeys raised from birth in filtered air. Tryptase- and chymase-positive cells were most abundant in trachea and least in terminal bronchioles. The majority of tryptase-positive and almost all chymase-positive cells were in extracellular matrix and smooth muscle bundles. Chronic exposure to HDMA elevated the abundance of both tryptase- and chymase-positive cells in the trachea and intrapulmonary bronchi. Neither exposure to O(3) nor HDMA + O(3) increased mast cell accumulations in the airway wall. We conclude that during postnatal airway development (1) mast cells are a resident airway cell population even in the absence of toxic air contaminants; (2) aeroallergen exposure alters large airway mast cell distribution and abundance, increasing chymase-positive mast cells; and (3) this response is attenuated by exposure to oxidant air pollutants.

Entities:  

Mesh:

Year:  2010        PMID: 20403968      PMCID: PMC2886865          DOI: 10.1093/toxsci/kfq119

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  49 in total

Review 1.  Immunopathology and human mast cell cytokines.

Authors:  P Bradding; S T Holgate
Journal:  Crit Rev Oncol Hematol       Date:  1999-07       Impact factor: 6.312

2.  Relationship of small airway chymase-positive mast cells and lung function in severe asthma.

Authors:  Silvana Balzar; Hong Wei Chu; Matthew Strand; Sally Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2004-11-24       Impact factor: 21.405

3.  Airway generation-specific differences in the spatial distribution of immune cells and cytokines in allergen-challenged rhesus monkeys.

Authors:  L A Miller; S D Hurst; R L Coffman; N K Tyler; M Y Stovall; D L Chou; L F Putney; L J Gershwin; E S Schelegle; C G Plopper; D M Hyde
Journal:  Clin Exp Allergy       Date:  2005-07       Impact factor: 5.018

4.  Stem cell factor is localized in, released from, and cleaved by human mast cells.

Authors:  A de Paulis; G Minopoli; E Arbustini; G de Crescenzo; F Dal Piaz; P Pucci; T Russo; G Marone
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

Review 5.  Asthma, genes, and air pollution.

Authors:  Robert J McCunney
Journal:  J Occup Environ Med       Date:  2005-12       Impact factor: 2.162

6.  Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide.

Authors:  M W Kofford; L B Schwartz; N M Schechter; D R Yager; R F Diegelmann; M F Graham
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

7.  Chronic aeroallergen during infancy enhances eotaxin-3 expression in airway epithelium and nerves.

Authors:  Debbie L Chou; Bruce L Daugherty; Erin K McKenna; Willy M Hsu; Nancy K Tyler; Charles G Plopper; Dallas M Hyde; Edward S Schelegle; Laurel J Gershwin; Lisa A Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04-15       Impact factor: 6.914

8.  Airway inflammation in mild intermittent and in persistent asthma.

Authors:  A M Vignola; P Chanez; A M Campbell; F Souques; B Lebel; I Enander; J Bousquet
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

Review 9.  The role of protease activation of inflammation in allergic respiratory diseases.

Authors:  Charles E Reed; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2004-11       Impact factor: 10.793

10.  Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell.

Authors:  Carole A Oskeritzian; Wei Zhao; Hae-Ki Min; Han-Zhang Xia; Andrea Pozez; Jonathan Kiev; Lawrence B Schwartz
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

View more
  4 in total

Review 1.  Biochemical effects of ozone on asthma during postnatal development.

Authors:  Richard L Auten; W Michael Foster
Journal:  Biochim Biophys Acta       Date:  2011-01-27

2.  Lung gene expression in a rhesus allergic asthma model correlates with physiologic parameters of disease and exhibits common and distinct pathways with human asthma and a mouse asthma model.

Authors:  Alexander R Abbas; Janet K Jackman; Sherron L Bullens; Sarah M Davis; David F Choy; Grazyna Fedorowicz; Martha Tan; Bao-Tran Truong; Y Gloria Meng; Lauri Diehl; Lisa A Miller; Edward S Schelegle; Dallas M Hyde; Hilary F Clark; Zora Modrusan; Joseph R Arron; Lawren C Wu
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

3.  Increased CCL24/eotaxin-2 with postnatal ozone exposure in allergen-sensitized infant monkeys is not associated with recruitment of eosinophils to airway mucosa.

Authors:  Debbie L Chou; Joan E Gerriets; Edward S Schelegle; Dallas M Hyde; Lisa A Miller
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-12       Impact factor: 4.219

4.  Mast cell-derived neurotrophin 4 mediates allergen-induced airway hyperinnervation in early life.

Authors:  K R Patel; L Aven; F Shao; N Krishnamoorthy; M G Duvall; B D Levy; X Ai
Journal:  Mucosal Immunol       Date:  2016-02-10       Impact factor: 7.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.